Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE)

Phytotherapy Research

Volumn 13, Issue 7, 1999, Pages 601-608

  Vedavanam, Krishnaveni ^a   Srijayanta, Sairavee ^a   O'Reilly, James ^a   Raman, Amala ^a   Wiseman, Helen ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antidiabetic; Antioxidant; Brush border membrane vesicles; Glucose transport; Liposomal lipid peroxidation; Soyabean phytochemical extract

Indexed keywords

ANTIDIABETIC AGENT; DAIDZEIN; EQUOL; ESTRADIOL; GENISTEIN; GENISTIN; ISOFLAVONE; KAEMPFEROL; LOW DENSITY LIPOPROTEIN; PHLORIZIN; PHYTOESTROGEN; PLANT EXTRACT; QUERCETIN;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ESTROGEN THERAPY; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; INTESTINE ABSORPTION; INTESTINE BRUSH BORDER MEMBRANE; LIPID PEROXIDATION; MEMBRANE VESICLE; NONHUMAN; OXIDATION; RABBIT; SOYBEAN;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, EXPERIMENTAL; GENISTEIN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; HUMANS; ISOFLAVONES; LIPOPROTEINS, LDL; MEMBRANE GLYCOPROTEINS; MICROVILLI; MONOSACCHARIDE TRANSPORT PROTEINS; OXIDATIVE STRESS; PLANT EXTRACTS; RABBITS; SODIUM-GLUCOSE TRANSPORTER 1; SOYBEANS;

ANIMALIA; BACTERIA (MICROORGANISMS); GLYCINE MAX; ORYCTOLAGUS CUNICULUS;

EID: 0032709304     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199911)13:7<601::AID-PTR550>3.0.CO;2-O     Document Type: Article

References (46)

1. Aldercreutz, C. H. T., Goldin, B. R., Gorbach, S. L. et al. (1995). Soybean phytoestrogen intake and cancer risk. J. Nutr. 125, 757S-770S.
2. Andersson, B., Mattson, L. A., Hahn, L. et al. (1997). Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82, 638-643.
3. Arai, K., Iizuka, S., Tada, Y., Oikawa, K., and Taniguchi, N. (1987). Increase in the glycosylated form of erythrocyte Cu-Zn superoxide dismutase in diabetes and close association of the non-enzymatic glucosylation with the enzyme activity. Biochim. Biophys Acta 924, 292-296.
4. Balkau, B., Shipley, M., Jarrett, R. J. et al. (1998). High blood glucose concentration is a risk factor for mortality in middleaged nondiabetic men. Diabetes Care 21, 360-367.
5. Bell, G. I., Burant, C. F., Takeda, J., and Gould, G. W. (1993). Structure and function of mammalian facilitative sugar transporters. J. Biol. Chem. 268, 19161-19164.
6. Bowey, E., Rowland, I., Adlercreutz, H., Sanders, T. A. B., and Wiseman, H. (1999). Inter-individual variation in soya isoflavone metabolism. Proc. Nutr. Soc. 57, 161A.
7. Bradford, M. M. (1976). Rapid and sensitive method for quantification of microgram quantities of protein utilisation: the principle of protein dye binding. Anal. Biochem. 72, 248-254.
8. Brussaard, H. E., Gevers-Leuven, J. A., Kluft, C. et al. (1997). Effect of 17β-oestradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 17, 324-330.
9. Burant, C. F., Flink, S., Depaoli, M. et al. (1994). Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes. J. Clin. Invest. 93, 578-585.
10. Clarkson, T. B., Anthony, M. S., and Hughes, C. L. Jr. (1995) Estrogenic soybean isoflavones and chronic disease: risks and benefits, Trend. Endocrinol. Metab. 6, 11-16.
11. Espeland, M. A., Hogan, P. E., Fineberg, S. E. et al. (1998). Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 21, 1589-1595.
12. +-dependent nutrient absorption in streptozotocin-treated chronically diabetic rats. J. Clin. Invest. 79, 1571-1578.
13. Fedorak, R. N., Cheeseman, C. I., Thomson, B. R., and Porter, V. M. (1991). Altered glucose carrier expression: mechanism of intestinal adaptation during streptozotocin-induced diabetic rats. Am. J. Physiol. 261 (Gastrointest. Liver. Physiol. 24) G585-G591.
14. Ferguson, D. R., Matthews, E. K., O'Connor, M. D. L., and Schuz, A. D. (1981). The interaction of phenformin and phlorizin with brush border membrane vesicles, phospholipid liposomes and phospholipid liposomes containing brush border membrane protein. Biochem. Pharmacol. 30, 1613-1619.
15. Gabal, L. L., Goodman-Gruen, D., and Barett-Connor, E. (1997). The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus. Am. J. Public Health 87, 443-445.
16. Gutteridge, J. M. C. (1993). Free radicals in disease processes: a compilation of cause and consequence. Free Rad. Res. Comm. 3, 141-158.
17. Harris, M. I., and Eastman, R. C. (1998). Is there a glycemic threshold for mortality risk? Diabetes Care 21, 331-333.
18. Hopfer, U., Sigrist-Nelson, K., Perroto, J., and Isselbacher, K. J. (1973). Glucose transport in isolated brush border membrane vesicles from rat small intestine. J. Biol. Chem. 248, 25-32.
19. Jain, S. K. (1989). Hyperglycaemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem. 264, 21340-21345.
20. Karpen, C. W., Cataland, S., O'Dorisio, T. M., and Pangamala, R. V. (1984). Interrelation of platelet vitamin E and thromboxane synthesis in Type I diabetes mellitus. Diabetes 33, 239-243.
21. Kessler, M., Acoto, O., Storelli, C., Murer, H., Muler, M., and Semenza, G. (1978). A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Biochem. Biophys. Acta 506, 136-154.
22. +-independent D-glucose transporter in the enterocyte basolateral membrane: orientation and cytochalasin B binding characteristics. J. Membrane Biol. 97, 259-266.
23. Markwell, M. A., Haas, S. M., Bieber, L. L., and Tobert, N. E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210.
24. Morton, M. S., Wilcox, G., Wahlqviat, M. L., and Griffiths, K. (1994). Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142, 251-259.
25. Norberasco, G., Odetti, P., Boeri, D., Maiello, M., and Adenzati, L. (1991). Malondialdehyde (MDA) level) in diabetic subjects. Relationship with blood glucose and glycosilated haemoglobin. Biomed. Pharmacol. 45, 193-196.
26. O'Reilly, J., Pollard, L., Leake, D., Sanders, T. A. B., and Wiseman, H. (1997). Quercetin is a potent inhibitor of oxidative damage to human LDL isolated from fresh and frozen plasma. Proc. Nutr. Soc. 56, 287A.
27. O'Reilly, J., Dean, T. S., Bowey, E., Rowland, I., Sanders, T. A. B., and Wiseman, H. (1998). The influence of dietary isoflavones on markers of lipid peroxidation in healthy male and female volunteers. Proc. Nutr. Soc. 57, 123A.
28. O'Reilly, J. D., Ridgway, T. J., Tucker, G. A., and Wiseman, H. (1999). Natural derivatives of phloridzin show potent antioxidant activity in human low density lipoproteins. Proc. Nutr. Soc. 57, 139A.
29. Ridgway, T., O'Reilly, J., West, G., Tucker, G., and Wiseman, H. (1997a). Antioxidant action of novel derivatives of the apple-derived flavonoid phloridzin compared to oestrogen: relevance to potential cardioprotective action. Biochem. Soc. Trans. 25, 106S.
30. Ridgway, T. J., Tucker, G., and Wiseman, H. (1997b). Novel bioconversions for the production of designer antioxidant and colourant flavonoids using polyphenol oxidases. In Biotechnology and Genetic Engineering Reviews, ed. by Tombs, M., volume 14, pp. 165-190 Intercept Press, Andover, UK.
31. Raines, E. W., and Ross, R. (1995). Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. J. Nutr. 125, 624S-630S.
32. Redgrave, T. G., Roberts, D. C. K., and West, C. E. (1975). Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65, 42-49.
33. Rumsey, S. C., Galeano, N. F., Arad, Y., and Deckelbaum, R. J. (1992). Cryopreservation with sucrose maintains the normal physical and biological properties of human plasma low-density lipoproteins. J. Lipid Res. 33, 1551-1561.
34. Schmitz, J., Preiser, H., Maestracci, D., Ghosh, B. K., Cerda, J. J., and Crane, R. K. (1973). Purification of the human intestinal brush border membrane. Biochim. Biophys. Acta 323, 98-112.
35. Thorens, B. (1996). Glucose transporters in the regulation of intestinal, renal and liver glucose fluxes (Review). Am. J. Physiol. 270 (Gastrointest. Liver. Physiol. 33), G541-G553.
36. Thornalley, P. J. (1988). Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J. 254, 751-755.
37. Vera, J. C., Reyes, A. M., Carcamo, J. G. et al. (1996). Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter GLUT1. J. Biol. Chem. 271, 8719-8724.
38. Virgili, F., Battistini, N., Canali, R., Vannini, V., and Tomasi, A. (1996). High glucose-induced membrane lipid peroxidation on intact erythrocytes and on isolated erythrocyte membrane (ghosts). Nutr. Biochem. 7, 156-161.
39. Wilson, W. F. (1998). Do estrogens reduce glycemic levels? Diabetes Care 21, 1585-1588.
40. Wiseman, H., Paganga, G., Rice-Evans, C., and Halliwell, B. (1993). Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins. A mechanism accounting for the cardioprotective action of tamoxifen? Biochem. J. 292, 635-638.
41. Wiseman, H. (1998). Phytochemicals (b) Epidemiological factors. Encyclopaedia of Human Nutrition, pp. 1549-1561. Academic Press, London.
42. Wiseman, H. (1999). The bioavailability of non-nutrient plant factors: dietary flavonoids and phytoestrogens. Invited Symposium Paper. Proc. Nutr. Soc. 58, 139-146.
43. Witzum, J. L. (1994). The oxidation hypothesis of atherosclerosis. Lancet 344, 792-795.
44. Wolff, S. P., and Dean, R. T. (1987). Glucose oxidation and protein modification. Biochem J. 245, 243-250.
45. Zhou, Y. C., and Zheng, R. L. (1991). Phenolic compounds and an analogue as superoxide anion scavengers and antioxidants. Biochem. Pharmacol. 42, 1177-1179.
46. Zuckerman, S. H., and Bryan, N. (1996). Inhibition of LDL oxidation and myeloperoxidase tyrosyl radical formation by the selective estrogen receptor modulator raloxifene (LY 139481 HCI). Atherosclerosis 126, 65-75.